- Home
- IMCC vs SCNI Comparison
IMCC vs SCNI Comparison
Compare IMCC & SCNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IMCC | SCNI |
|---|---|---|
| Founded | 1980 | 2003 |
| Country | Canada | Israel |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0M | 1.2M |
| IPO Year | 2019 | 2014 |
Fundamental Metrics
Financial Performance| Metric | IMCC | SCNI |
|---|---|---|
| Price | $0.68 | $0.48 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 71.7K | ★ 1.1M |
| Earning Date | 11-16-2026 | 08-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 50.00 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $60.66 | N/A |
| Revenue Next Year | $6.68 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.09 | $0.21 |
| 52 Week High | $8.65 | $3.58 |
Technical Indicators
Market Signals| Indicator | IMCC | SCNI |
|---|---|---|
| Relative Strength Index (RSI) | 33.61 | 28.27 |
| Support Level | $0.60 | $0.43 |
| Resistance Level | $1.05 | $1.07 |
| Average True Range (ATR) | 0.12 | 0.09 |
| MACD | -0.04 | -0.00 |
| Stochastic Oscillator | 2.26 | 17.11 |
Price Performance
Historical ComparisonAbout IMCC IM Cannabis Corp.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority revenue is generated from Germany, and also has its presence in Israel.
About SCNI Scinai Immunotherapeutics Ltd.
Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units: (i) Scinai R&D, focused on the development of therapeutics in inflammation and immunology, and (ii) the contract development and manufacturing organization (CDMO) business. The CDMO business provides integrated development and manufacturing services to small and emerging biotech companies, supporting clients from early-stage development through clinical-stage production.